Zepp Health Co. (NYSE:ZEPP - Get Free Report) was the recipient of a large drop in short interest during the month of April. As of April 30th, there was short interest totalling 18,200 shares, a drop of 21.9% from the April 15th total of 23,300 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily volume of 65,500 shares, the days-to-cover ratio is presently 0.3 days.
Zepp Health Stock Performance
Shares of NYSE:ZEPP traded down $0.02 on Friday, hitting $0.86. The company's stock had a trading volume of 74,571 shares, compared to its average volume of 50,269. Zepp Health has a 12 month low of $0.82 and a 12 month high of $2.10. The stock's 50-day moving average is $0.97 and its two-hundred day moving average is $1.22. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.49 and a current ratio of 2.04. The company has a market capitalization of $52.84 million, a price-to-earnings ratio of -1.76 and a beta of 0.88.
Zepp Health (NYSE:ZEPP - Get Free Report) last released its earnings results on Monday, March 18th. The company reported ($0.02) EPS for the quarter. The company had revenue of $84.47 million for the quarter. Zepp Health had a negative net margin of 8.66% and a negative return on equity of 8.55%.
Analysts Set New Price Targets
Separately, Fundamental Research set a $4.96 price objective on Zepp Health and gave the stock a "buy" rating in a research report on Tuesday, March 26th.
Get Our Latest Report on ZEPP
Zepp Health Company Profile
(
Get Free Report)
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals.
See Also
Before you consider Zepp Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.
While Zepp Health currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
